Brief: Bayer To Acquire Perfuse Therapeutics For Deal Valued Up To $2.45 Billion
May 6 (Reuters) - Bayer AG BAYGn.DE: BAYER TO ACQUIRE PERFUSE THERAPEUTICS TO COMPLEMENT OPHTHALMOLOGY PIPELINE BAYER AG - DEAL VALUED UP TO $2.45 BILLION WITH $300 MILLION UPFRONT PAYMENT Source text: ID:nBw3vqdYYa Further company coverage: [BAYGn.DE] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)